Stroke recurrence and its prevention in patients with patent foramen ovale

J U Harrer1, T Wessels, A Franke

  • 1Department of Neurology, Aachen University Hospital, Aachen, Germany.

Insights

Medical or invasive treatments for stroke in patent foramen ovale (PFO) patients show low recurrence. Previous ischemic events and larger shunts are key risk factors for recurrent strokes.

Area of Science:

  • Neurology
  • Cardiology
  • Vascular Medicine

Background:

  • Patent foramen ovale (PFO) is a suspected cause of cryptogenic stroke.
  • Optimal treatment strategies to prevent recurrent ischemic events remain unclear.
  • The role of concomitant risk factors in stroke recurrence requires further elucidation.

Purpose of the Study:

  • To compare the effectiveness of medical versus invasive (catheter or surgical) treatments for PFO-related stroke prevention.
  • To identify risk factors associated with recurrent ischemic events in patients with PFO.

Main Methods:

  • A prospective observational study followed 124 patients with cryptogenic cerebral ischemia and PFO for a mean of 52 months.
  • Patients were treated medically (n=83), with transcatheter closure (n=34), or surgical closure (n=7).
  • Recurrent ischemic events and associated risk factors were analyzed.

Main Results:

  • Annual stroke recurrence rates were low and comparable between medical and catheter-treated groups (2.9% vs. 2.1%).
  • Patients with recurrent strokes had significantly larger shunts (OR=5.0) and a history of previous ischemic events (OR=4.4).
  • Pulmonary embolism and case fatality rates were higher in patients experiencing stroke recurrence.

Conclusions:

  • The absolute risk of recurrent cerebrovascular events is low with medical or catheter interventional therapy for PFO.
  • Previous ischemic events and shunt size are significant risk factors for recurrence.
  • Randomized controlled trials are recommended to definitively establish optimal treatment strategies.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...